BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 15983909)

  • 1. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
    Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
    Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
    Falagas ME; Matthaiou DK; Bliziotis IA
    J Antimicrob Chemother; 2006 Apr; 57(4):639-47. PubMed ID: 16501057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis: randomized controlled trials of clindamycin/aminoglycoside vs. beta-lactam monotherapy for the treatment of intra-abdominal infections.
    Falagas ME; Matthaiou DK; Karveli EA; Peppas G
    Aliment Pharmacol Ther; 2007 Mar; 25(5):537-56. PubMed ID: 17305755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside/beta-lactam combinations in clinical practice.
    Leibovici L; Paul M
    J Antimicrob Chemother; 2007 Nov; 60(5):911-2. PubMed ID: 17890282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin/metronidazole versus beta-lactam-based treatment of intra-abdominal infections: a meta-analysis of comparative trials.
    Matthaiou DK; Peppas G; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2006 Sep; 28(3):159-65. PubMed ID: 16899353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolones versus beta-lactam based regimens for the treatment of osteomyelitis: a meta-analysis of randomized controlled trials.
    Karamanis EM; Matthaiou DK; Moraitis LI; Falagas ME
    Spine (Phila Pa 1976); 2008 May; 33(10):E297-304. PubMed ID: 18449029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis.
    Vardakas KZ; Tansarli GS; Bliziotis IA; Falagas ME
    Int J Antimicrob Agents; 2013 Apr; 41(4):301-10. PubMed ID: 23410791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials.
    Marcus R; Paul M; Elphick H; Leibovici L
    Int J Antimicrob Agents; 2011 Jun; 37(6):491-503. PubMed ID: 21292449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emergence of resistance to beta-lactam antibiotics during treatment of Pseudomonas aeruginosa lower respiratory tract infections: is combination therapy the solution?
    Nichols L; Maki DG
    Chemioterapia; 1985 Feb; 4(1):102-9. PubMed ID: 3986938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
    Paul M; Silbiger I; Grozinsky S; Soares-Weiser K; Leibovici L
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003344. PubMed ID: 16437452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moxifloxacin monotherapy versus beta-lactam-based standard therapy for community-acquired pneumonia: a meta-analysis of randomised controlled trials.
    An MM; Zou Z; Shen H; Gao PH; Cao YB; Jiang YY
    Int J Antimicrob Agents; 2010 Jul; 36(1):58-65. PubMed ID: 20400271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis.
    Paul M; Lador A; Grozinsky-Glasberg S; Leibovici L
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003344. PubMed ID: 24395715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short- versus long-course antibiotic therapy for acute pyelonephritis in adolescents and adults: a meta-analysis of randomized controlled trials.
    Kyriakidou KG; Rafailidis P; Matthaiou DK; Athanasiou S; Falagas ME
    Clin Ther; 2008 Oct; 30(10):1859-68. PubMed ID: 19014841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ciprofloxacin vs an aminoglycoside in combination with a beta-lactam for the treatment of febrile neutropenia: a meta-analysis of randomized controlled trials.
    Bliziotis IA; Michalopoulos A; Kasiakou SK; Samonis G; Christodoulou C; Chrysanthopoulou S; Falagas ME
    Mayo Clin Proc; 2005 Sep; 80(9):1146-56. PubMed ID: 16178494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-lactam antibiotic versus combined β-lactam antibiotics and single daily dosing regimens of aminoglycosides for treating serious infections: A meta-analysis.
    Heffernan AJ; Sime FB; Sun J; Lipman J; Kumar A; Andrews K; Ellwood D; Grimwood K; Roberts J
    Int J Antimicrob Agents; 2020 Mar; 55(3):105839. PubMed ID: 31704215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropaenia.
    Paul M; Soares-Weiser K; Grozinsky S; Leibovici L
    Cochrane Database Syst Rev; 2002; (2):CD003038. PubMed ID: 12076467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis.
    Paul M; Soares-Weiser K; Leibovici L
    BMJ; 2003 May; 326(7399):1111. PubMed ID: 12763980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of intravenous {beta}-lactam/macrolide versus {beta}-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia.
    Tessmer A; Welte T; Martus P; Schnoor M; Marre R; Suttorp N
    J Antimicrob Chemother; 2009 May; 63(5):1025-33. PubMed ID: 19293196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside combinations versus beta-lactams alone for penetrating abdominal trauma: a meta-analysis.
    Hooker KD; DiPiro JT; Wynn JJ
    J Trauma; 1991 Aug; 31(8):1155-60. PubMed ID: 1831511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis: ertapenem for complicated intra-abdominal infections.
    Falagas ME; Peppas G; Makris GC; Karageorgopoulos DE; Matthaiou DK
    Aliment Pharmacol Ther; 2008 May; 27(10):919-31. PubMed ID: 18266994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.